GRD Biotechnology Acquisition Ltd

GRD Biotechnology Acquisition Ltd, trading on Nasdaq under the ticker CGRD, is a blank check company incorporated in the Cayman Islands and focused on identifying a merger target in the biotechnology and life sciences sector. The company completed its initial public offering in 2023 and, as of mid-2024, remained in the target-search phase of its lifecycle. In July 2024, the SEC recorded a staff action against the company — accession number 9999999997-24-003066 — an administrative filing typically associated with compliance or delinquency proceedings. The SPAC is sponsored through an affiliated sponsor entity bearing the GRD Biotech name. For complete filing history, deal timelines, and real-time status on CGRD, sign up for full data access at SpacDesk.